Annexon’s ANX007 Misses GA Endpoint, But May Have Visual Acuity Path Forward

 
• By Alaric DeArment
Annexon announced results of the Phase II ARCHER study of ANX007 in geographic atrophy • Source: Shutterstock

More from Sensory

More from Therapeutic Category